57.8
BriaCell Therapeutics Corp.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
42.3
FY23:
26.9
FY24:
3.65
FY25:
19.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.25
FY22:
0.23
FY23:
0.22
FY24:
2.22
FY25:
1.72
Total assets
Change from FY21 to FY25
millions USD
FY21:
58.0
FY22:
42.6
FY23:
27.2
FY24:
5.87
FY25:
21.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.56
FY22:
0.94
FY23:
1.80
FY24:
7.46
FY25:
3.98
(negative)
Change from FY21 to FY24
millions USD
FY21:
29.8
FY22:
31.3
FY23:
29.1
FY24:
1.10
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
27.7
FY22:
10.3
FY23:
−3.78
FY24:
−2.68
FY25:
17.3
Total liabilities & equity
Change from FY21 to FY24
millions USD
FY21:
58.0
FY22:
42.6
FY23:
27.2
FY24:
5.87
FY25:
–
All amounts in millions USD